Učitavanje...

Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types

PURPOSE: The efficacy and safety of regorafenib have been demonstrated in phase 3 trials for multiple tumor types, including metastatic colorectal cancer (mCRC) (CORRECT [NCT01103323]; CONCUR [NCT01584830]), advanced gastrointestinal stromal tumor (GIST) (GRID [NCT01271712]), and hepatocellular carc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Manag Res
Glavni autori: Hofheinz, Ralf-Dieter, Bruix, Jordi, Demetri, George D, Grothey, Axel, Marian, Marisca, Bartsch, Jennifer, Odom, Dawn
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285228/
https://ncbi.nlm.nih.gov/pubmed/34285574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S305939
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!